{"gao_id": "GAO-16-12", "published": "2015-10-23T12:00:00Z", "released": "2015-11-20T07:00:00Z", "summary": "", "title": "Medicare Part B: Expenditures for New Drugs Concentrated among a Few Drugs, and Most Were Costly for Beneficiaries", "topics": ["Substance abuse treatment", "Blood diseases", "Cancer", "Infectious diseases", "Health Care", "Diseases", "Federal spending", "Beneficiaries", "Breast cancer", "Claims", "Physicians", "Prescription drugs", "Medicare", "Fee-for-service plans", "Biologics", "Orphans"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-16-12", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-16-12-highlights.pdf"}, {"title": "Full Report (39 pages)", "url": "https://www.gao.gov/assets/gao-16-12.pdf"}, {"title": "Accessible PDF (43 pages)", "url": "https://www.gao.gov/assets/680/673538.pdf"}]}